DAXCERB Trademark

Trademark Overview


On Tuesday, August 26, 2025, a trademark application was filed for DAXCERB with the United States Patent and Trademark Office. The USPTO has given the DAXCERB trademark a serial number of 99358530. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 3, 2026. This trademark is owned by Pfizer Inc.. The DAXCERB trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Veterinary pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Smoking cessation preparations; Vaccines for human use
daxcerb

General Information


Serial Number99358530
Word MarkDAXCERB
Filing DateTuesday, August 26, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 3, 2026

Trademark Statements


Goods and ServicesVeterinary pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Veterinary pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Smoking cessation preparations; Vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 26, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192

Trademark Events


Event DateEvent Description
Tuesday, August 26, 2025NEW APPLICATION ENTERED
Tuesday, August 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 26, 2025APPLICATION FILING RECEIPT MAILED
Monday, January 12, 2026ASSIGNED TO EXAMINER
Monday, January 12, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 28, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 30, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 30, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 30, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 30, 2026TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 3, 2026PUBLISHED FOR OPPOSITION
Tuesday, February 3, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED